DORC is listed on the portfolio pages of Eurazeo (portfolio page) and Montagu Private Equity (portfolio page). Montagu Private Equity lists it as current; Eurazeo lists it as exited. Eurazeo invested in DORC in 2019, per Eurazeo's portfolio page.
DORC is a Healthcare company. Its owner on record, Eurazeo, is a buyout firm founded in 2001, headquartered in Paris, France, with €35 billion under management. Eurazeo lists 266 companies in the index, 34 of them in Healthcare. Also backed by Montagu Private Equity.
Eurazeo is a leading French private equity firm and investment group that manages a diversified portfolio of over 600 companies.
Read the Eurazeo profileMontagu Private Equity is a carve-out specialist that invests in businesses providing must-have products and services.
Read the Montagu Private Equity profileDORC is listed on the portfolio pages of Eurazeo (portfolio page) and Montagu Private Equity (portfolio page). Montagu Private Equity lists it as current; Eurazeo lists it as exited. Eurazeo invested in DORC in 2019, per Eurazeo's portfolio page.
DORC is in Healthcare. Classified from the owner's portfolio label.
Eurazeo is headquartered in Paris, France.
Eurazeo lists 33 other Healthcare companies in the index, including 3P Biopharmaceuticals, Amolyt Pharma, Bioserenity, C2S and Cardiologs Technologies.
6 of 265 shown
See the full Eurazeo portfolio.
6 of 55 shown
See the full Montagu Private Equity portfolio.
Browse PE-backed companies.
